Advances in the understanding of plaque composition and treatment options: Year in review

Journal of the American College of Cardiology

Volumn 63, Issue 16, 2014, Pages 1604-1616

  Tomey, Matthew I ^a   Narula, Jagat ^a   Kovacic, Jason C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerotic plaque; imaging; inflammation; PCSK9; statins

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CD163 ANTIGEN; COLCHICINE; ENZYME INHIBITOR; FLUORODEOXYGLUCOSE F 18; HAPTOGLOBIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6 RECEPTOR; LIVER X RECEPTOR AGONIST; LOSMAPIMOD; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRIAL DNA; PHOSPHOLIPASE A2; PLACEBO; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 INHIBITOR; R 211945; RANOLAZINE; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; UNCLASSIFIED DRUG; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IN VIVO STUDY; INTRAVASCULAR ULTRASOUND; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; MOLECULAR IMAGING; NON INVASIVE MEASUREMENT; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG RESPONSE; DRUG TARGETING; ENZYME INHIBITION; INFLAMMATION; INTERMETHOD COMPARISON; LOCAL THERAPY; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCYTE; OXIDATIVE STRESS; PATIENT IDENTIFICATION; REVIEW; SYSTEMIC THERAPY; TREATMENT OUTCOME; VASCULITIS;

ATHEROSCLEROTIC PLAQUE; IMAGING; INFLAMMATION; PCSK9; STATINS;

DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OXIDATIVE STRESS; PLAQUE, ATHEROSCLEROTIC;

EID: 84899019876     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.042     Document Type: Review

References (105)

1. M. Naghavi, P. Libby, and E. Falk et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I Circulation 108 2003 1664 1672
2. J.A. Ambrose, M.A. Tannenbaum, and D. Alexopoulos et al. Angiographic progression of coronary artery disease and the development of myocardial infarction J Am Coll Cardiol 12 1988 56 62
3. W.E. Boden, R.A. O'Rourke, and K.K. Teo et al. Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
4. H.C. Stary, A.B. Chandler, and R.E. Dinsmore et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 92 1995 1355 1374
5. J. Narula, M. Nakano, and R. Virmani et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques J Am Coll Cardiol 61 2013 1041 1051
6. G.B. Mancini, P.M. Hartigan, and E.R. Bates et al. Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE trial Circ Cardiovasc Interv 4 2011 545 552
7. G.W. Stone, A. Maehara, and A.J. Lansky et al. A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
8. R. Puri, S.J. Nicholls, S.G. Ellis, E.M. Tuzcu, and S.R. Kapadia High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression J Am Coll Cardiol 63 2014 1134 1140
9. J. Mann, and M.J. Davies Mechanisms of progression in native coronary artery disease: role of healed plaque disruption Heart 82 1999 265 268
10. J. Sun, H.R. Underhill, D.S. Hippe, Y. Xue, C. Yuan, and T.S. Hatsukami Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study J Am Coll Cardiol Img 5 2012 798 804
11. A. Ghattas, H.R. Griffiths, A. Devitt, G.Y. Lip, and E. Shantsila Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 62 2013 1541 1545
12. P. Dutta, G. Courties, and Y. Wei et al. Myocardial infarction accelerates atherosclerosis Nature 487 2012 325 329
13. C.S. Robbins, I. Hilgendorf, and G.F. Weber et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis Nat Med 19 2013 1166 1172
14. G.J. Randolph Proliferating macrophages prevail in atherosclerosis Nat Med 19 2013 1094 1095
15. S. Wantha, J.E. Alard, and R.T. Megens et al. Neutrophil-derived cathelicidin promotes adhesion of classical monocytes Circ Res 112 2013 792 801
16. G. Sarlon-Bartoli, Y. Bennis, and R. Lacroix et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis J Am Coll Cardiol 62 2013 1436 1441
17. N. Sarwar, A.S. Butterworth, and D.F. Freitag et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies Lancet 379 2012 1205 1213
18. A.D. Hingorani, and J.P. Casas The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis Lancet 379 2012 1214 1224
19. K.R. Purushothaman, M. Purushothaman, and A.P. Levy et al. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis J Am Coll Cardiol 60 2012 112 119
20. L.E. Cahill, A.P. Levy, and S.E. Chiuve et al. Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin J Am Coll Cardiol 61 2013 728 737
21. A.V. Finn, M. Nakano, and R. Polavarapu et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques J Am Coll Cardiol 59 2012 166 177
22. E. Yu, P.A. Calvert, and J.R. Mercer et al. Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans Circulation 128 2013 702 712
23. D.J. Rader, and A.R. Tall The not-so-simple HDL story: is it time to revise the HDL cholesterol hypothesis? Nat Med 18 2012 1344 1346
24. B. Hewing, K.J. Moore, and E.A. Fisher HDL and cardiovascular risk: time to call the plumber? Circ Res 111 2012 1117 1120
25. P.J. Barter, M. Caulfield, and M. Eriksson et al. Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 357 2007 2109 2122
26. G.G. Schwartz, A.G. Olsson, and M. Abt et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome N Engl J Med 367 2012 2089 2099
27. AIM-HIGH Investigators, W.E. Boden, J.L. Probstfield, and T. Anderson et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
28. B.F. Voight, G.M. Peloso, and M. Orho-Melander et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 2012 572 580
29. R.H. Mackey, P. Greenland, D.C. Goff Jr., D. Lloyd-Jones, C.T. Sibley, and S. Mora High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 60 2012 508 516
30. S. Mora, R.J. Glynn, and P.M. Ridker High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy Circulation 128 2013 1189 1197
31. M. Riwanto, L. Rohrer, and B. Roschitzki et al. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling Circulation 127 2013 891 904
32. L.S. Rallidis, C.C. Tellis, and J. Lekakis et al. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up J Am Coll Cardiol 60 2012 2053 2060
33. J.A. DiDonato, Y. Huang, and K.S. Aulak et al. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma Circulation 128 2013 1644 1655
34. W. Chen, D.P. Cormode, and Y. Vengrenyuk et al. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression J Am Coll Cardiol Img 6 2013 373 384
35. M.P. Bonaca, B.M. Scirica, and M.S. Sabatine et al. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol 60 2012 332 338
36. K. Chan, R.S. Patel, and P. Newcombe et al. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis J Am Coll Cardiol 61 2013 957 970
37. A. Ganda, M. Magnusson, and L. Yvan-Charvet et al. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis Circulation 127 2013 988 996
38. N.K. Gupta, J.A. de Lemos, C.R. Ayers, S.M. Abdullah, D.K. McGuire, and A. Khera The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study J Am Coll Cardiol 60 2012 1148 1155
39. O.M. Khan, M.K. Akula, and K. Skalen et al. Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice Circulation 127 2013 782 790
40. N.T. Le, K.S. Heo, and Y. Takei et al. A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis Circulation 127 2013 486 499
41. A.A. Mahabadi, M.H. Berg, and N. Lehmann et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall study J Am Coll Cardiol 61 2013 1388 1395
42. S. Mani, H. Li, and A. Untereiner et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis Circulation 127 2013 2523 2534
43. W.H. Tang, Z. Wang, and B.S. Levison et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk N Engl J Med 368 2013 1575 1584
44. R.A. Koeth, Z. Wang, and B.S. Levison et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis Nat Med 19 2013 576 585
45. H. Xiao, M. Lu, and T.Y. Lin et al. Sterol Regulatory Element Binding Protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility Circulation 128 2013 632 642
46. D. Baldassarre, A. Hamsten, and F. Veglia et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study J Am Coll Cardiol 60 2012 1489 1499
47. M.J. Budoff, R. Young, and V.A. Lopez et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 61 2013 1231 1239
48. M. Naya, V.L. Murthy, and C.R. Foster et al. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease J Am Coll Cardiol 61 2013 2098 2106
49. D.E. Rifkin, J.H. Ix, C.L. Wassel, M.H. Criqui, and M.A. Allison Renal artery calcification and mortality among clinically asymptomatic adults J Am Coll Cardiol 60 2012 1079 1085
50. H. Sillesen, P. Muntendam, and A. Adourian et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study J Am Coll Cardiol Img 5 2012 681 689
51. P.H. Stone, S. Saito, and S. Takahashi et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study Circulation 126 2012 172 181
52. K. Toutouzas, C. Grassos, and M. Drakopoulou et al. First in vivo application of microwave radiometry in human carotids: a new noninvasive method for detection of local inflammatory activation J Am Coll Cardiol 59 2012 1645 1653
53. U. Baber, G.W. Stone, and G. Weisz et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes J Am Coll Cardiol Img 5 2012 S53 S61
54. A.J. Lansky, V.G. Ng, and A. Maehara et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes J Am Coll Cardiol Img 5 2012 S62 S72
55. S.P. Marso, N. Mercado, and A. Maehara et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes J Am Coll Cardiol Img 5 2012 S42 S52
56. Z. Zhao, B. Witzenbichler, and G.S. Mintz et al. Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial J Am Coll Cardiol Img 6 2013 86 95
57. Y. Kataoka, K. Wolski, and K. Uno et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound J Am Coll Cardiol 59 2012 1592 1597
58. Y. Xu, G.S. Mintz, and A. Tam et al. Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) Circulation 126 2012 537 545
59. P.A. Calvert, D.R. Obaid, and M. O'Sullivan et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study J Am Coll Cardiol Img 4 2011 894 901
60. E. Falk, and R.L. Wilensky Prediction of coronary events by intravascular imaging J Am Coll Cardiol Img 5 2012 S38 S41
61. W.M. Suh, A.H. Seto, R.J. Margey, I. Cruz-Gonzalez, and I.K. Jang Intravascular detection of the vulnerable plaque Circ Cardiovasc Imaging 4 2011 169 178
62. T. Thim, M.K. Hagensen, and D. Wallace-Bradley et al. Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease Circ Cardiovasc Imaging 3 2010 384 391
63. J.L. Fleg, G.W. Stone, and Z.A. Fayad et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions J Am Coll Cardiol Imaging 5 2012 941 955
64. M.D. Radu, and E. Falk In search of vulnerable features of coronary plaques with optical coherence tomography: is it time to rethink the current methodological concepts? Eur Heart J 33 2012 9 12
65. G.J. Tearney, E. Regar, and T. Akasaka et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J Am Coll Cardiol 59 2012 1058 1072
66. K. Kato, T. Yonetsu, and S.J. Kim et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study J Am Coll Cardiol Intv 5 2012 1150 1158
67. K. Kato, T. Yonetsu, and S.J. Kim et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study Circ Cardiovasc Imaging 5 2012 433 440
68. S. Uemura, K. Ishigami, and T. Soeda et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques Eur Heart J 33 2012 78 85
69. H. Jia, F. Abtahian, and A.D. Aguirre et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography J Am Coll Cardiol 62 2013 1748 1758
70. D.R. Obaid, P.A. Calvert, and D. Gopalan et al. Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology Circ Cardiovasc Imaging 6 2013 655 664
71. P. Maurovich-Horvat, C.L. Schlett, and H. Alkadhi et al. The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography J Am Coll Cardiol Img 5 2012 1243 1252
72. K. Otsuka, S. Fukuda, and A. Tanaka et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome J Am Coll Cardiol Img 6 2013 448 457
73. M. Karolyi, H. Seifarth, and G. Liew et al. Classification of coronary atherosclerotic plaques ex vivo with T1, T2, and ultrashort echo time CMR J Am Coll Cardiol Img 6 2013 466 474
74. K.C. Briley-Saebo, T.H. Nguyen, and A.M. Saeboe et al. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes J Am Coll Cardiol 59 2012 616 626
75. E.A. Osborn, and F.A. Jaffer The year in molecular imaging J Am Coll Cardiol Img 5 2012 317 328
76. T. Quillard, and P. Libby Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development Circ Res 111 2012 231 244
77. J. Sanz, and Z.A. Fayad Imaging of atherosclerotic cardiovascular disease Nature 451 2008 953 957
78. M.R. Dweck, M.W. Chow, and N.V. Joshi et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology J Am Coll Cardiol 59 2012 1539 1548
79. M.D. Majmudar, J. Yoo, and E.J. Keliher et al. Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques Circ Res 112 2013 755 761
80. N.V. Joshi, A.T. Vesey, and M.C. Williams et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial Lancet 383 2014 705 713
81. M. Fiechter, J. Stehli, T.A. Fuchs, S. Dougoud, O. Gaemperli, and P.A. Kaufmann Impact of cardiac magnetic resonance imaging on human lymphocyte DNA integrity Eur Heart J 34 2013 2340 2345
82. P.M. Ridker, E. Danielson, and F.A. Fonseca et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
83. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
84. K. Hattori, Y. Ozaki, and T.F. Ismail et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS J Am Coll Cardiol Img 5 2012 169 177
85. A.S. Kini, U. Baber, and J.C. Kovacic et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy) J Am Coll Cardiol 62 2013 21 29
86. S.E. Nissen, S.J. Nicholls, and I. Sipahi et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
87. R. Puri, S.E. Nissen, and M. Shao et al. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy Eur Heart J 34 2013 3182 3190
88. A. Tawakol, Z.A. Fayad, and R. Mogg et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study J Am Coll Cardiol 62 2013 909 917
89. E. Vucic, C. Calcagno, and S.D. Dickson et al. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin J Am Coll Cardiol Img 5 2012 819 828
90. M. Elkhawad, J.H. Rudd, and L. Sarov-Blat et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis J Am Coll Cardiol Img 5 2012 911 922
91. S.M. Nidorf, J.W. Eikelboom, C.A. Budgeon, and P.L. Thompson Low-dose colchicine for secondary prevention of cardiovascular disease J Am Coll Cardiol 61 2013 404 410
92. D. Urban, J. Poss, M. Bohm, and U. Laufs Targeting the proprotein convertase subtilisin/kexin type 9 (PCSK9) for the treatment of dyslipidemia and atherosclerosis J Am Coll Cardiol 62 2013 1401 1408
93. R.P. Giugliano, N.R. Desai, and P. Kohli et al. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study Lancet 380 2012 2007 2017
94. M.J. Koren, R. Scott, and J.B. Kim et al. Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study Lancet 380 2012 1995 2006
95. F. Raal, R. Scott, and R. Somaratne et al. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial Circulation 126 2012 2408 2417
96. D. Sullivan, A.G. Olsson, and R. Scott et al. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial JAMA 308 2012 2497 2506
97. N. Ferri, G. Tibolla, and A. Pirillo et al. Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels Atherosclerosis 220 2012 381 386
98. D.S. Wald, J.K. Morris, and N.J. Wald et al. Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 369 2013 1115 1123
99. H. Watabe, A. Sato, and D. Akiyama et al. Impact of coronary plaque composition on cardiac troponin elevation after percutaneous coronary intervention in stable angina pectoris: a computed tomography analysis J Am Coll Cardiol 59 2012 1881 1888
100. T. Kodama, T. Kondo, A. Oida, S. Fujimoto, and J. Narula Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention J Am Coll Cardiol Intv 5 2012 636 643
101. B.E. Claessen, A. Maehara, M. Fahy, K. Xu, G.W. Stone, and G.S. Mintz Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention J Am Coll Cardiol Img 5 2012 S111 S118
102. G.W. Stone, A. Abizaid, and S. Silber et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-Segment elevation myocardial infarction: the MASTER trial J Am Coll Cardiol 60 2012 1975 1984
103. T.S. Kristensen, K.F. Kofoed, J.T. Kuhl, W.B. Nielsen, M.B. Nielsen, and H. Kelbaek Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: a multidetector computed tomography study J Am Coll Cardiol 58 2011 502 509
104. F.Y. Lin, L.J. Shaw, and A.M. Dunning et al. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography J Am Coll Cardiol 58 2011 510 519
105. S.J. Nicholls, A. Hsu, and K. Wolski et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome J Am Coll Cardiol 55 2010 2399 2407